from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2634c/PE_PGRS46

LFCtreatmentdescriptionclass of inhibitor

0.676

Amikacinug/mL Amikacintranslation

1.255

Cap5-10ug/mL Capreomycintranslation

1.318

Rox10-50 ug/mL Roxithromycintranslation

-0.173

SM2-5 ug/mL Streptomycintranslation

0.700

Tet5-10 ug/mL Tetracyclinetranslation

-1.204

Rif0.2-5ug/mL Rifampicintranscription

-1.174

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.148

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.694

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.285

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.231

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.370

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.184

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.139

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.725

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.575

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.073

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.455

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.395

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.427

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.976

KCN5-20 ug/mL Potassium cyaniderespiration

-0.189

NaN30.2-2 mM Sodium aziderespiration

-0.142

Nigericin50 uM Nigericinrespiration

-0.870

TRC10-150 ug/mL Triclosanrespiration

1.053

TRZ10-25 ug/mL Thioridazinerespiration

2.813

Valinomycin0.5-10 uM Valinomycinrespiration

-0.161

ZnSO42 mM ZnSO4respiration

0.734

menadione6-10 ug/mL Menadionerespiration

-0.337

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.542

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.699

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.550

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.003

NRP_1Non-replicating persistence stage 1dosRassociated

-0.389

Amp0.2mg/mL AmpicillincellWall

0.231

Cephalexin20-100 ug/mL CephalexincellWall

-0.685

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.487

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.200

EMB10-20 ug/mL EthambutolcellWall

-0.451

Eta12-40 ug/mL EthionamidecellWall

-0.368

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.750

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.168

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.694

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.274

BZA0.12 mg/mL BenzamidearomaticAmides

-0.114

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.443

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.245

H2O24 mM hydrogen peroxideDNAdamaging

-1.092

Levo10 ug/mL LevofloxacinDNAdamaging

-0.733

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.779

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.542

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.190

UVUV-irradiationDNAdamaging

0.751

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.739

Antimycin12.5-50 ug/mL Antimycin A?

-0.152

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.722

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.050

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.759

PA8240.2-2 ug/mL PA-824?

1.028

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.225

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.041

Verapamil50 uM Verapamil?

-0.309

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.113

methoxatin10-20 ug/mL Methoxatin?